日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

CROCuS,一项评估利利马托韦治疗年龄≥28天至≤3岁呼吸道合胞病毒急性呼吸道感染患儿的抗病毒活性、临床疗效和安全性的II期研究

Ferrero, Fernando; Lin, Chien-Yu; Liese, Johannes; Luz, Kleber; Stoeva, Tatyana; Nemeth, Agnes; Gijón, Manuel; Calvo, Cristina; Natalini, Silvina; Toh, Teck-Hock; Deleu, Sofie; Chen, Bohang; Rusch, Sarah; Sánchez, Beatriz López; Leipoldt, Illse; Vijgen, Leen; Huntjens, Dymphy; Baguet, Tristan; Bertzos, Kristi; Gamil, Mohamed; Stevens, Marita

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

一项随机、双盲 II 期临床试验,旨在评估单剂量阿替芬诺和哌喹联合治疗对成人和儿童单纯性恶性疟疾的疗效、安全性、耐受性和药代动力学。

Macintyre, Fiona; Adoke, Yeka; Tiono, Alfred B; Duong, Tran Thanh; Mombo-Ngoma, Ghyslain; Bouyou-Akotet, Marielle; Tinto, Halidou; Bassat, Quique; Issifou, Saadou; Adamy, Marc; Demarest, Helen; Duparc, Stephan; Leroy, Didier; Laurijssens, Bart E; Biguenet, Sophie; Kibuuka, Afizi; Tshefu, Antoinette Kitoto; Smith, Melnick; Foster, Chanelle; Leipoldt, Illse; Kremsner, Peter G; Phuc, Bui Quang; Ouedraogo, Alphonse; Ramharter, Michael